FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24595611000001106: Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    79913201000001110 Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    79913301000001118 Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Is a Alfuzosin hydrochloride 10mg m/r tablet false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Has active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Is a Alfuzosin 10mg modified-release tablets false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) 30 tablet Has AMP False Alfuzosin 10mg modified-release tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start